Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

QONTRAST

K-Number: K040399 · 2004-03-29

ApplicantAmid
Decision Date2004-03-29
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

QONTRAST is the device name listed in this FDA 510(k) record. The listed applicant is Amid. It received FDA 510(k) clearance on 2004-03-29 under 510(k) number K040399. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the QONTRAST?

QONTRAST is a medical device that received FDA 510(k) clearance on 2004-03-29. The listed applicant is Amid. The 510(k) number is K040399.

When did QONTRAST receive FDA 510(k) clearance?

QONTRAST received FDA 510(k) clearance on 2004-03-29, under 510(k) number K040399.

Who is the listed applicant for QONTRAST?

The FDA 510(k) record lists Amid as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for QONTRAST?

The FDA product code for QONTRAST is LLZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑